These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32838584)

  • 61. The theoretical impact and cost-effectiveness of vaccines that protect against sexually transmitted infections and disease.
    Garnett GP
    Vaccine; 2014 Mar; 32(14):1536-42. PubMed ID: 24606635
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Interventions to prevent sexually transmitted infections, including HIV infection.
    Marrazzo JM; Cates W
    Clin Infect Dis; 2011 Dec; 53 Suppl 3(Suppl 3):S64-78. PubMed ID: 22080271
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Toward global prevention of sexually transmitted infections (STIs): the need for STI vaccines.
    Gottlieb SL; Low N; Newman LM; Bolan G; Kamb M; Broutet N
    Vaccine; 2014 Mar; 32(14):1527-35. PubMed ID: 24581979
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Tumour virus vaccines: hepatitis B virus and human papillomavirus.
    Stanley M
    Philos Trans R Soc Lond B Biol Sci; 2017 Oct; 372(1732):. PubMed ID: 28893935
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Prevalence of Human Papillomavirus, Human Immunodeficiency Virus, and Other Sexually Transmitted Infections Among Men Who Have Sex With Men in Togo: A National Cross-sectional Survey.
    Ferré VM; Gbeasor-Komlanvi FA; Collin G; Dagnra AC; Le Hingrat Q; Jaquet A; Salou M; Descamps D; Charpentier C; Ekouevi DK
    Clin Infect Dis; 2019 Aug; 69(6):1019-1026. PubMed ID: 30520971
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cross-Protection against MERS-CoV by Prime-Boost Vaccination Using Viral Spike DNA and Protein.
    Choi JA; Goo J; Yang E; Jung DI; Lee S; Rho S; Jeong Y; Park YS; Park H; Moon YH; Park U; Seo SH; Lee H; Lee JM; Cho NH; Song M; Kim JO
    J Virol; 2020 Nov; 94(24):. PubMed ID: 32967955
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Comparison of different forms of herpes simplex replication-defective mutant viruses as vaccines in a mouse model of HSV-2 genital infection.
    Da Costa XJ; Morrison LA; Knipe DM
    Virology; 2001 Sep; 288(2):256-63. PubMed ID: 11601897
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Production of EV71 vaccine candidates.
    Chong P; Hsieh SY; Liu CC; Chou AH; Chang JY; Wu SC; Liu SJ; Chow YH; Su IJ; Klein M
    Hum Vaccin Immunother; 2012 Dec; 8(12):1775-83. PubMed ID: 22992566
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Emerging human papillomavirus vaccines.
    Christensen ND
    Expert Opin Emerg Drugs; 2005 Feb; 10(1):5-19. PubMed ID: 15757400
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A Single-Cycle Glycoprotein D Deletion Viral Vaccine Candidate, ΔgD-2, Elicits Polyfunctional Antibodies That Protect against Ocular Herpes Simplex Virus.
    Ramsey NLM; Visciano M; Hunte R; Loh LN; Burn Aschner C; Jacobs WR; Herold BC
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32295919
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Single-Dose Vaccination with a Hepatotropic Adeno-associated Virus Efficiently Localizes T Cell Immunity in the Liver with the Potential To Confer Rapid Protection against Hepatitis C Virus.
    Mekonnen ZA; Grubor-Bauk B; English K; Leung P; Masavuli MG; Shrestha AC; Bertolino P; Bowen DG; Lloyd AR; Gowans EJ; Wijesundara DK
    J Virol; 2019 Oct; 93(19):. PubMed ID: 31292249
    [TBL] [Abstract][Full Text] [Related]  

  • 72. An intravaginal ring that releases three antiviral agents and a contraceptive blocks SHIV-RT infection, reduces HSV-2 shedding, and suppresses hormonal cycling in rhesus macaques.
    Derby N; Aravantinou M; Kenney J; Ugaonkar SR; Wesenberg A; Wilk J; Kizima L; Rodriguez A; Zhang S; Mizenina O; Levendosky K; Cooney ML; Seidor S; Gettie A; Grasperge B; Blanchard J; Piatak M; Lifson JD; Fernández-Romero J; Zydowsky TM; Robbiani M
    Drug Deliv Transl Res; 2017 Dec; 7(6):840-858. PubMed ID: 28600625
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Gardasil administration to hr-HPV-positive women and their partners.
    Gizzo S; Noventa M; Nardelli GB
    Trends Pharmacol Sci; 2013 Sep; 34(9):479-80. PubMed ID: 23896431
    [No Abstract]   [Full Text] [Related]  

  • 74. CCL19 and CCL28 Assist Herpes Simplex Virus 2 Glycoprotein D To Induce Protective Systemic Immunity against Genital Viral Challenge.
    Yan Y; Hu K; Fu M; Deng X; Luo S; Tong L; Guan X; He S; Li C; Jin W; Du T; Zheng Z; Zhang M; Liu Y; Hu Q
    mSphere; 2021 Apr; 6(2):. PubMed ID: 33910988
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Development of vaccines against the sexually transmitted infections gonorrhoea, syphilis, Chlamydia, herpes simplex virus, human immunodeficiency virus and Zika virus.
    McIntosh EDG
    Ther Adv Vaccines Immunother; 2020; 8():2515135520923887. PubMed ID: 32647779
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Sexually transmitted acute infection with a clustered genotype 4 hepatitis C virus in HIV-1-infected men and inefficacy of early antiviral therapy.
    Serpaggi J; Chaix ML; Batisse D; Dupont C; Vallet-Pichard A; Fontaine H; Viard JP; Piketty C; Rouveix E; Rouzioux C; Weiss L; Pol S
    AIDS; 2006 Jan; 20(2):233-40. PubMed ID: 16511416
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Induction and maintenance of bi-functional (IFN-γ + IL-2+ and IL-2+ TNF-α+) T cell responses by DNA prime MVA boosted subtype C prophylactic vaccine tested in a Phase I trial in India.
    Munusamy Ponnan S; Pattabiram S; Thiruvengadam K; Goyal R; Singla N; Mukherjee J; Chatrath S; Bergin P; T Kopycinski J; Gilmour J; Kumar S; Muthu M; Subramaniam S; Swaminathan S; Prasad Tripathy S; Luke HE
    PLoS One; 2019; 14(3):e0213911. PubMed ID: 30921340
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Human papillomavirus vaccination. Consensus Conference in pediatric age].
    Bartolozzi G; Bona G; Ciofi M; De Martino M; Di Pietro P; Duse M; Esposito S; Gasparini R; Mariani L; Marostica G; Paravati F; Plebani A; Principi N; Zuccotti GV; Tovo PA
    Minerva Pediatr; 2007 Jun; 59(3):165-82. PubMed ID: 17519861
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Vaccines to prevent infections by oncoviruses.
    Schiller JT; Lowy DR
    Annu Rev Microbiol; 2010; 64():23-41. PubMed ID: 20420520
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Priming with a Potent HIV-1 DNA Vaccine Frames the Quality of Immune Responses prior to a Poxvirus and Protein Boost.
    Asbach B; Kibler KV; Köstler J; Perdiguero B; Yates NL; Stanfield-Oakley S; Tomaras GD; Kao SF; Foulds KE; Roederer M; Seaman MS; Montefiori DC; Parks R; Ferrari G; Forthal DN; Phogat S; Tartaglia J; Barnett SW; Self SG; Gottardo R; Cristillo AD; Weiss DE; Galmin L; Ding S; Heeney JL; Esteban M; Jacobs BL; Pantaleo G; Wagner R
    J Virol; 2019 Feb; 93(3):. PubMed ID: 30429343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.